Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-23

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for hydrochlorothiazide from Oxford Pharmaceuticals, LLC. This action pertains to regulatory approval of a supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)